Showing 463 results
-
Press release /Q2 net sales were flat (0% cc[1]) as Growth Products[2] offset Gleevec generic impact Gilenya (USD 811 million, +17% cc) continued to grow double-digit mainly due to volume growth Cosentyx (…
-
Press release /Continuing operations[1] saw sales, core[2] operating income and core EPS grow (cc[2]) in Q1 Net sales were USD 11.9 billion (-7%, +3% cc)[2] Operating income was USD 2.8 billion (-1%, +15% cc)…
-
Story /Working with a nonprofit, Novartis is helping train healthcare workers to diagnose and treat chronic ailments such as diabetes.
-
Story /Novartis worked with doctors, patients and government officials in the Yaroslavl region of Russia to address high death rates from stroke and heart disease.
-
Story /Novartis researchers aim to preserve kidney function – and quality of life – for patients.
-
Story /Novartis is investing in a novel type of medicine to reduce the risk of heart disease.
-
Story /Speaking with Ganesh Prasanna, Director of Ophthalmology at NIBR.
-
Story /Novartis is strongly committed in helping and supporting employees impacted by cancer through the program Ensemble – Caring for Colleagues (Ensemble).
-
Story /Ron Hollander, president of the International Neuroendocrine Cancer Alliance, talks to us about patient advocacy.